Campden BRI 00510618 false 2024-01-01 2024-12-31 2024-12-31 2024-12-31 The principal activity of the company is the provision of scientific and technical services to the food and drink supply chain. This is achieved by providing a broad portfolio of services to member companies and commercial and Government clients. These activities are focused on five key business platforms: Digita Accounts Production Advanced 6.30.9574.0 true true true true true true true false false false 00510618 2024-01-01 2024-12-31 00510618 2024-12-31 00510618 bus:Consolidated 2024-12-31 00510618 bus:Consolidated 2 2024-12-31 00510618 2 2024-12-31 00510618 core:AcceleratedTaxDepreciationDeferredTax bus:Consolidated 2024-12-31 00510618 core:OtherDeferredTax bus:Consolidated 2024-12-31 00510618 core:RevaluationPropertyDeferredTax bus:Consolidated 2024-12-31 00510618 core:TaxLossesCarry-forwardsDeferredTax bus:Consolidated 2024-12-31 00510618 core:RetainedEarningsAccumulatedLosses 2024-12-31 00510618 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-12-31 00510618 core:RevaluationReserve bus:Consolidated 2024-12-31 00510618 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-12-31 00510618 core:CurrentFinancialInstruments 2024-12-31 00510618 core:CurrentFinancialInstruments bus:Consolidated 2024-12-31 00510618 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 00510618 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2024-12-31 00510618 core:Non-currentFinancialInstruments 2024-12-31 00510618 core:Non-currentFinancialInstruments bus:Consolidated 2024-12-31 00510618 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 00510618 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2024-12-31 00510618 core:DevelopmentCostsCapitalisedDevelopmentExpenditure bus:Consolidated 2024-12-31 00510618 core:BetweenTwoFiveYears bus:Consolidated 2024-12-31 00510618 core:MoreThanFiveYears bus:Consolidated 2024-12-31 00510618 core:WithinOneYear bus:Consolidated 2024-12-31 00510618 core:PensionPlan2 bus:Consolidated 2024-12-31 00510618 core:PensionPlan3 bus:Consolidated 2024-12-31 00510618 core:PensionPlan4 bus:Consolidated 2024-12-31 00510618 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-12-31 00510618 core:LandBuildings bus:Consolidated 2024-12-31 00510618 core:MotorVehicles bus:Consolidated 2024-12-31 00510618 core:OtherPropertyPlantEquipment bus:Consolidated 2024-12-31 00510618 core:DeferredTaxation bus:Consolidated 2024-12-31 00510618 core:OtherProvisionsContingentLiabilities 2024-12-31 00510618 core:OtherProvisionsContingentLiabilities bus:Consolidated 2024-12-31 00510618 bus:FRS102 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Audited bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:FullAccounts bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:RegisteredOffice bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Director1 2024-01-01 2024-12-31 00510618 bus:Director1 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Director10 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Director11 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Director22 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Director23 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Director9 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:HighestPaidDirector bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:CompanyLimitedByGuarantee bus:Consolidated 2024-01-01 2024-12-31 00510618 bus:ConsolidatedGroupCompanyAccounts 2024-01-01 2024-12-31 00510618 core:FinancialGuarantees 2024-01-01 2024-12-31 00510618 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 00510618 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2024-01-01 2024-12-31 00510618 core:RevaluationReserve bus:Consolidated 2024-01-01 2024-12-31 00510618 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2024-01-01 2024-12-31 00510618 countries:Europe bus:Consolidated 2024-01-01 2024-12-31 00510618 countries:RestWorldOutsideEurope bus:Consolidated 2024-01-01 2024-12-31 00510618 countries:UnitedKingdom bus:Consolidated 2024-01-01 2024-12-31 00510618 core:DevelopmentCostsCapitalisedDevelopmentExpenditure bus:Consolidated 1 2024-01-01 2024-12-31 00510618 core:OtherResidualIntangibleAssets bus:Consolidated 2024-01-01 2024-12-31 00510618 core:PensionPlan2 bus:Consolidated 2024-01-01 2024-12-31 00510618 core:PensionPlan3 bus:Consolidated 2024-01-01 2024-12-31 00510618 core:PensionPlan4 bus:Consolidated 2024-01-01 2024-12-31 00510618 core:Buildings bus:Consolidated 2024-01-01 2024-12-31 00510618 core:FurnitureFittingsToolsEquipment bus:Consolidated 2024-01-01 2024-12-31 00510618 core:LandBuildings bus:Consolidated 2024-01-01 2024-12-31 00510618 core:MotorVehicles bus:Consolidated 2024-01-01 2024-12-31 00510618 core:OtherPropertyPlantEquipment bus:Consolidated 2024-01-01 2024-12-31 00510618 core:PlantMachinery bus:Consolidated 2024-01-01 2024-12-31 00510618 core:DeferredTaxation bus:Consolidated 2024-01-01 2024-12-31 00510618 core:OtherProvisionsContingentLiabilities 2024-01-01 2024-12-31 00510618 core:OtherProvisionsContingentLiabilities bus:Consolidated 2024-01-01 2024-12-31 00510618 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-01-01 2024-12-31 00510618 core:Subsidiary1 2024-01-01 2024-12-31 00510618 core:Subsidiary1 1 2024-01-01 2024-12-31 00510618 core:Subsidiary2 2024-01-01 2024-12-31 00510618 core:Subsidiary2 1 2024-01-01 2024-12-31 00510618 core:Subsidiary2 countries:Hungary 2024-01-01 2024-12-31 00510618 core:ForeignTax bus:Consolidated 2024-01-01 2024-12-31 00510618 core:UKTax bus:Consolidated 2024-01-01 2024-12-31 00510618 countries:EnglandWales bus:Consolidated 2024-01-01 2024-12-31 00510618 2023-12-31 00510618 bus:Consolidated 2023-12-31 00510618 core:RetainedEarningsAccumulatedLosses 2023-12-31 00510618 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2023-12-31 00510618 core:RevaluationReserve bus:Consolidated 2023-12-31 00510618 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2023-12-31 00510618 core:DevelopmentCostsCapitalisedDevelopmentExpenditure bus:Consolidated 2023-12-31 00510618 core:CostValuation 2023-12-31 00510618 core:PensionPlan4 bus:Consolidated 2023-12-31 00510618 core:FurnitureFittingsToolsEquipment bus:Consolidated 2023-12-31 00510618 core:LandBuildings bus:Consolidated 2023-12-31 00510618 core:MotorVehicles bus:Consolidated 2023-12-31 00510618 core:OtherPropertyPlantEquipment bus:Consolidated 2023-12-31 00510618 core:DeferredTaxation bus:Consolidated 2023-12-31 00510618 core:OtherProvisionsContingentLiabilities 2023-12-31 00510618 core:OtherProvisionsContingentLiabilities bus:Consolidated 2023-12-31 00510618 2023-12-31 00510618 bus:Consolidated 2023-12-31 00510618 bus:Consolidated 2 2023-12-31 00510618 bus:Consolidated core:PreviouslyStatedAmount 2023-12-31 00510618 2 2023-12-31 00510618 core:AcceleratedTaxDepreciationDeferredTax bus:Consolidated 2023-12-31 00510618 core:OtherDeferredTax bus:Consolidated 2023-12-31 00510618 core:RevaluationPropertyDeferredTax bus:Consolidated 2023-12-31 00510618 core:TaxLossesCarry-forwardsDeferredTax bus:Consolidated 2023-12-31 00510618 core:CurrentFinancialInstruments 2023-12-31 00510618 core:CurrentFinancialInstruments bus:Consolidated 2023-12-31 00510618 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 00510618 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2023-12-31 00510618 core:Non-currentFinancialInstruments 2023-12-31 00510618 core:Non-currentFinancialInstruments bus:Consolidated 2023-12-31 00510618 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 00510618 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2023-12-31 00510618 core:BetweenTwoFiveYears bus:Consolidated 2023-12-31 00510618 core:MoreThanFiveYears bus:Consolidated 2023-12-31 00510618 core:WithinOneYear bus:Consolidated 2023-12-31 00510618 core:PensionPlan4 bus:Consolidated 2023-12-31 00510618 core:FurnitureFittingsToolsEquipment bus:Consolidated 2023-12-31 00510618 core:LandBuildings bus:Consolidated 2023-12-31 00510618 core:MotorVehicles bus:Consolidated 2023-12-31 00510618 core:OtherPropertyPlantEquipment bus:Consolidated 2023-12-31 00510618 bus:HighestPaidDirector bus:Consolidated 2023-01-01 2023-12-31 00510618 bus:Consolidated 2023-01-01 2023-12-31 00510618 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 00510618 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2023-01-01 2023-12-31 00510618 core:RevaluationReserve bus:Consolidated 2023-01-01 2023-12-31 00510618 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2023-01-01 2023-12-31 00510618 countries:Europe bus:Consolidated 2023-01-01 2023-12-31 00510618 countries:RestWorldOutsideEurope bus:Consolidated 2023-01-01 2023-12-31 00510618 countries:UnitedKingdom bus:Consolidated 2023-01-01 2023-12-31 00510618 core:PensionPlan4 bus:Consolidated 2023-01-01 2023-12-31 00510618 core:Subsidiary1 1 2023-01-01 2023-12-31 00510618 core:Subsidiary2 1 2023-01-01 2023-12-31 00510618 core:ForeignTax bus:Consolidated 2023-01-01 2023-12-31 00510618 core:UKTax bus:Consolidated 2023-01-01 2023-12-31 00510618 core:RetainedEarningsAccumulatedLosses 2022-12-31 00510618 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2022-12-31 00510618 core:RevaluationReserve bus:Consolidated 2022-12-31 00510618 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 00510618

Campden BRI

Annual Report and Consolidated Financial Statements

for the Year Ended 31 December 2024

 

Campden BRI

Contents

Company Information

1

Chair's Statement

2

Chief Executive's Statement

3

Strategic Report

4 to 8

Directors' Report

9 to 11

Statement of Directors' Responsibilities

12

Independent Auditor's Report

13 to 15

Consolidated Profit and Loss Account

16

Consolidated Balance Sheet

17

Balance Sheet

18

Consolidated Statement of Changes in Equity

19

Statement of Changes in Equity

20

Consolidated Statement of Cash Flows

21

Notes to the Financial Statements

22 to 41

 

Campden BRI

Company Information

Directors

P E Moody

P J Headridge

C Ikpeme

A L Kyriakides

S K Newbitt

C M T Pronto-Hussey

Company secretary

C Ikpeme

Registered office

Station Road
Chipping Campden
Gloucestershire
GL55 6LD

Auditors

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Campden BRI

Chair's Statement for the Year Ended 31 December 2024

2024 was a year of investment for Campden BRI with improvements in infrastructure and systems being launched as well as a strategic review of our services and research requirements.

A major programme is being implemented to improve our internal processes and procedures to enable Campden BRI to adapt to the evolution that is ever present in the food and drink sector, to improve the competitiveness of the our services and enable Campden BRI to remain at the heart of our Members' requirements. This programme includes new systems which will help us reduce response times and improve accessibility for our Members and includes, for example, developing a Member focussed portal to allow electronic interaction.

We are also upgrading our management information systems to allow us to better manage our resources and make more informed decisions.

These improvements involve expenditure both of an operating and capital nature resulting in costs being incurred in the year impacting on our reported loss to the extent of £871,581 (included within Exceptional Items - see Note 6 to the accounts). Accordingly, the underlying profit for the year before taking these investments into account was £748,359 which compares to the result for the prior year of £1,508,218.

In the absence of capital from our shareholders, the challenge that Campden BRI faces as a Member owned organisation is that the only money available for investment and research comes from the profit that we generate and this has been depleted in recent years by contributions that have had to be made to recover the deficit in the defined benefit pensions schemes that resulted from the financial crisis of 2008/09. However, these contributions linked to improved bond yields have resulted in a material reduction in these deficits and the Board is now seeking to reduce these contributions to release more profit for investment and research.

Our previous Chair, Sebastian Munden, resigned in May of this year in order to pursue his other activities and I was appointed as your Chair on 1st July 2025. I am sure you will join me in thanking Seb for his excellent contribution during his period as Chair and to wish to him well in all that he does. For my part, I am both delighted and honoured to be appointed Chair of such a highly respected and long standing research institute that is vital to the future of the food and drink industries which we serve as the only truly independent company in the sector meeting the science and technology needs of our Members. The active engagement of hundreds of businesses in our fifteen Member Interest Groups (MIGs) is testimony to the continued importance our Members see in the power of a membership-based organisation focussed on delivering for the benefit of its Member companies and wider stakeholders.

Finally, and most importantly, I wish to acknowledge the contribution of our outstanding colleagues for it is their hard work and dedication that makes Campden BRI what it is, the most respected and trusted business in our sector.
 

P E Moody
Chair

29 September 2025

 

Campden BRI

Chief Executive's Statement for the Year Ended 31 December 2024

Despite the economic headwinds the business faced in 2024, I am pleased to report that the demand for our services remained consistent with 2023 with revenue increasing by 2% year on year. Our direct costs and overheads increased, as budgeted. This increase relates to our continued investment in our People and strategic investment programme.

The difficult decision was taken in January 2024 to consult on the closure of our Nutfield site which subsequently led to the site being fully decommissioned in July. This consolidation of our analytical services to our Chipping Campden site has delivered operational resilience and an opportunity to offer a superior service to our brewing members. We have invested in state-of-the-art capital analytical equipment and created a dedicated beverage analytical laboratory thus future proofing our facilities with the latest analytical methods and improved systems for the exceptional client service our members enjoy and deserve.

Our Wine Centre of Excellence, based in Guildford, Surrey, opened for business in July 2024 offering specialist analytical testing and consulting services to our clients in both the GB wine sector and to the substantial import wine market.

Our Operational Excellence programme continued in 2024 with various workstreams, across our Operational divisions and Support functions to modernise and invest in systems and processes which will accelerate our capacity for strategic growth.

This new strategy has focussed on delivering shorter term tangible outputs to serve our members with newly developed analytical methods and technology solutions.

In addition to externally funded research, Campden BRI invests in research for strategic purpose. In 2024, we:

Supported 6 PhD studentships

Published the latest edition of Guideline 42 (HACCP: a practical guide)

Completed paper on survival of pathogens in non-alcoholic beer

Completed Hepatitis E project leading to delivery of a new service

Launched ThermaGen as a new software product

Delivery of a new service following completion of effectiveness and application of natural antimicrobials

We published two R&D reports on other projects and 3 Research Summary sheets on others in 2024. All projects have been marketed and are on the member research webpage of the Campden BRI website.

We remain committed to delivering, in the most cost-effective way, an exceptional client experience, fostering diversity and inclusion, and reinforcing our capabilities to address the evolving opportunities for the food and drink industry.

As we navigate the continued challenges of the economic environment, we remain dedicated to our vision to be the trusted, premier, independent technical partner of choice to the food and drink industry, with great science and sustainability at the core of our plans.

P Headridge
Chief Executive

29 September 2025

 

Campden BRI

Strategic Report for the Year Ended 31 December 2024

The directors present their strategic report for the year ended 31 December 2024.

Principal activity

The principal activity of the Group is the provision of scientific and technical services to the food and drink supply chain. This is achieved by providing a broad portfolio of services to member companies and commercial and Government clients. These activities are focused on five key business platforms:

Membership
The close relationship with over 4,000 member companies in 90 countries around the world, through 1,450 membership accounts, helps ensure that the Group understands the needs of its principal clients, both individually and collectively. Membership of the organisation provides the opportunity to participate in Member Interest Groups (MIGs), which offer valuable insights and networking opportunities to connect with industry colleagues and peers. Additionally, membership includes special support services, preferential rates, and quick, free enquiries. This engagement provides an unrivalled view of the needs and opportunities for the food, drink, and allied industries.

Research & innovation
The Group carries out an ongoing research program in its own right and in collaboration with other research providers to meet the food industry's strategic aims and develop its service offerings and technical skills.

Analytical Services
The Group focuses its activities on those areas of complex analysis where the interpretation of results, innovative methods and the strength of the Campden BRI brand provide a unique selling point versus high-volume
operators. Significant investment in this area continues, which remains a key part of our activities. Continued refinement of the laboratory information management system (LIMS) is at the forefront of providing our clients
with a more rigorous, consistent and high-quality offering regarding analysis and reporting.

Consultancy
Through developing innovative technical and consulting services and close relationships with members, the Group provides clients with a broad range of bespoke services in the areas of Science and Technology. There
has been continued investment in the necessary equipment for such work in the Process Halls and Pilot Production capabilities.

Training and knowledge management
The provision of classroom and online scheduled and customised training, seminars and conference events, coupled with the provision of targeted technical databases, have been effective mechanisms to keep clients up to date, promote the Campden BRI brand, and help identify new market opportunities. Expansion of the Regulatory advisory services into international territories continue the Groups' commitment to continuous improvement and remaining relevant in an increasingly globalised economy.

 

Campden BRI

Strategic Report for the Year Ended 31 December 2024

Fair review of the business
 

The results for the year, as detailed in the statement of comprehensive income, show a turnover of £26,670,924, representing a 2% increase on the previous year’s £26,048,990. To remain well-positioned for the future, the Group implemented pay awards to stay competitive in the labour market and retain key skills, and increased headcount to improve customer service, reduce turnaround times and strengthen operational resilience. As a result, cost of sales and administrative expenses were higher, and the Group recorded a gross profit of £10,875,191 (2023: £11,657,989) and an operating profit of £858,612 (2023: £1,902,421).

The Group has agreed with the trustees of its defined benefit pension schemes on a schedule of contributions from profits to reduce scheme deficits. During the year, £1,440,000 was contributed (2023: £1,243,000). The deficit, excluding deferred tax, fell to £333,000 (2023: £7,387,000), primarily due to the impact of higher corporate bond yields. The increase in yields raised the discount rate used to calculate scheme liabilities, which in turn reduced the reported deficit.

The Group’s tangible fixed assets were valued at £13,654,366 (2023: £17,686,934), including a £4,175,000 downward revaluation of freehold property (2023: £nil). The valuation reflects a change in market conditions since 2022, primarily due to higher interest rates and rising property investment yields. The adjustment was recorded in the balance sheet revaluation reserve.

The Group also had net current assets of £1,206,740 (2023: £3,008,322). The change reflects cash outflows in the year arising from the Group’s investment in capability and service resilience, as well as exceptional expenses for a site closure, professional fees and legal expenses. Other working capital items were broadly stable.

Future developments

The Board is in the process of renewing the strategy for 2025-2028, aimed at guiding Campden BRI into its next phase of growth. This strategy will focus on leveraging our strengths and market position to serve our clients and members better. As part of this, a new research strategy has been formulated to ensure that the scientific excellence underpinning our services remains at the forefront of our industry. This approach is designed to deliver a more client-centric suite of services. The existing and upcoming services, shaped by our research program, are well-positioned to meet the challenges and opportunities of the food and drink sector in the coming years.

Key perfomance indicators

Campden BRI Group monitors the health of the business through a range of measures: health and safety, financial performance, staff investment, infrastructure and capital investment, standards of service, marketing and
communications, client feedback and business development. These are reviewed and monitored by the Executive Leadership Team regularly and reported to the Board as requested.

2024

2023

No. / %

No. / %

Health and Safety

RIDDOR accidents

1

2

Lost Time accidents

0

0

Membership

Number of member accounts

1,450

1,478

Staff investment

Training hours as a % of total hours

4.80%

4.37%

Digital engagement

Active website users *

299,634

329,204

Sessions (website visits)

521,683

531,290

Sessions per active user

1.74

1.61

* 2024 figures reflect a more prominent cookie opt-out policy, which typically reduces reported active users.

 

Campden BRI

Strategic Report for the Year Ended 31 December 2024

Risk management
The management of the business has identified a number of risks in the execution of the Group's strategy. The breadth of the Group's business and its reputation means that there are no direct competitors for the business as a whole, although several businesses compete directly in certain defined areas of the Group's business. Development of a new business strategy for 2025-28 is underway to ensure the business remains relevant to our membership's needs and is financially robust.

The Board has an Audit and Risk Committee of independent Non-Executive Directors, which meets at least four times a year to maintain regular risk oversight.

Market and commercial risks
The strong and active membership helps ensure that Campden BRI remains close to its core client base, allowing it to respond effectively and efficiently to clients’ changing needs in both the short and medium term.
Campden BRI has actively reduced its reliance on U.K. Government and EU funding as they continue to face budget challenges and increased uncertainty. Although Government tenders are reviewed for appropriateness, income is derived mainly from Membership fees (16%) and Commercial contracts (84%).

Operational risks
Business management practices and performance are detailed in a comprehensive business management system overseen by the Governance, Risk Management and Compliance team. The Group is also externally
audited and accredited to ISO 9001 and ISO 17025. The Board has continued to appoint and get feedback from Independent Scientific Advisers who reviewed the activities of Campden BRI, particularly in relation to the direction of research and formal engagement with member views. A detailed system for assessing and reporting health and safety is in place and reviewed regularly.

Financial instruments and risks
The Group is exposed to the usual credit and cash flow risks associated with selling on credit and manages these risks through credit control procedures. The nature of its financial instruments means that the price and liquidity risks are minimised by the predetermination of the Group's funding facilities and terms. Monthly management accounts are used to aid management in monitoring and directing business performance. The Audit and Risk Committee continues to oversee group performance and enhance the Board’s decision-making processes.

The Group participates in four defined benefit pension schemes, resulting in significant financial risk. The group's participation has been actively managed as part of a de-risking strategy. The Campden R.A. Pension Scheme was closed to future accrual of benefits from the end of 2010, the British Beer & Pub Association (BBPA) Group Pension Scheme in 2011, and the Flour Milling and Baking Research and Assurance (FMBRA) Scheme in 2012. The eligibility criteria for joining the Universities Superannuation Scheme (USS) was amended in 2013, which
limits additional future exposure.

The Group also recognises the risks attached to the need to provide adequate profits to maintain investments in facilities, staff and equipment. Capital investment in 2024 was £1,387,272 (2023 - £1,368,568), focusing on
laboratory and pilot plant equipment, improvements in I.T. and building refurbishment.

The Board constantly monitors the Group's trading results and revised projections as appropriate to ensure that the Group can meet its future obligations as they fall due. The Board does not consider there to be any significant risk to the financial position of the Group as a result of fluctuations in foreign exchange rates deflating or inflating the Group's foreign currency assets and liabilities.

 

Campden BRI

Strategic Report for the Year Ended 31 December 2024

Going concern
The Board evaluates whether the Group can continue as a going concern, meaning that there are no material uncertainties that could cast significant doubt on the Group's ability to operate effectively over the next twelve months from the approval date of the financial statements.

In assessing the Group's going concern status, the Board has considered the financial resources available alongside ongoing economic and geopolitical uncertainties. Although U.K. inflation has significantly decreased over the past year, the Board continues to monitor the lingering effects of COVID-19, the ongoing war in Ukraine, and potential volatility in energy markets. Scenarios have been modelled to assess these risks alongside the proactive measures the Group has taken to ensure its viability, as outlined earlier in this report. The base case scenario assumes that demand for the Group's services will continue through 2025 and 2026, supported by ongoing initiatives to enhance process efficiency and productivity.

The assumptions underlying these forecasts are subject to various sensitivities, including potential declines in revenue and demand. The base case has been stress-tested to consider scenarios where revenues and demand are lower than anticipated. As has been the case for many years, the forecasts also assume that the pension scheme trustees do not insist on paying the deficit in full or materially increasing the deficit repayment plan. The triennial valuations for the Campden R.A. and FMBRA schemes were submitted to the Pensions Regulator in March 2024, and they include an agreed-upon schedule of contributions. The Board and Trustees continue to have a good working relationship.

With the financial resources currently available to the Group, even with the additional stress described above, the Board believes that there is sufficient cash and committed facilities in place for the Group to meet its obligations for the foreseeable future. Therefore, the Financial Statements have been prepared on a going-concern basis.

Section 172(1) statement
The Board of Directors of Campden BRI, individually and collectively, consider that they have acted in good faith and in a manner likely to promote the Company's and Group's success for the benefit of its members in the decisions taken during the year.

During the year, we updated and implemented policies, systems, and procedures in accordance with our responsibilities to our stakeholders.

The Board considers that the primary stakeholder groups impacted by the Company's and Group's business activities and decisions include its employees, members, clients, pension trustees, lenders, suppliers, and local communities. We recognise the importance of our stakeholders to the success of the business.

We strive to be responsible employers and engage with our employees. They are fundamental in contributing to the success of the Company and the Group and delivering the best possible service to our members and clients. As a result, management meets regularly with employee representatives to facilitate an exchange of views and achieve a safe and successful business. In addition, all employees receive regular business updates from leadership. All employees are invited to participate in an annual staff engagement survey.

All staff and their immediate families have access to an employee assistance programme that provides confidential support from counsellors and financial, legal, and health advice. Ten of our employees are trained mental health first aiders.

The experience we deliver to members and clients is integral to the Group's brand and drives the business's success. Therefore, we continue to undertake an annual membership survey to assess customer satisfaction
feedback during the year, which informs our ongoing client experience program.

The Articles of Association, approved in November 2023, established an Advisory Council that the Board will actively meet with three times per year.

 

Campden BRI

Strategic Report for the Year Ended 31 December 2024

Section 172(1) statement (continued)
Suppliers are engaged regularly as they are vital to the business's ability to operate effectively. The directors agree on terms and establish policies to ensure adherence to supplier payment terms.

The Company and Group endeavour to positively impact the local community and environment, as this is essential to the staff, customers, and members. At our company-owned sites, all waste is recycled or incinerated to generate energy, and carbon dioxide emissions have continually reduced over the last four years.

Key decisions include health, safety, and the environment, commercial and financial strategy, capital expenditure, management of defined benefit pension schemes, and key management personnel's appointments.

The directors prioritise our employees' health, safety, and physical and mental welfare, which is a core value of the Company. We also diligently manage our responsibility to others who may be affected by our activities, such as contractors, visitors, and members of the public.

We are continually improving Campden BRI's occupational health and safety performance. We are committed to reducing risks through the continuous improvement of safe and effective processes and properly supervised systems of work in conjunction with appropriate consultation, communication, training and monitoring.

We have established rigorous and robust processes to ensure that we meet our statutory duties at all times and have appointed competent people to assist us in discharging this duty and in ensuring that a strong health and safety culture is embedded in our business. Health and safety performance is measured, reported on, and reviewed at every board meeting, and all safety incidents are investigated thoroughly. We actively encourage all employees to report accidents and near-misses.

The Board regularly participates in developing the business’s three-year strategy and monitoring its implementation against key performance indicators. In 2025 and 2026, the Board will devote time to understanding current and future industry needs and preparing to serve them best. Independent scientific advisors and a scientific and technical committee support the Board in overseeing the essential research programme.

The business is the employer sponsor of the defined benefit schemes, and the active engagement with the trustees is an important business relationship. Meetings are held a minimum of three times per year to brief the trustees on business performance, review the funds' performance, and consult on investment and funding decisions.

To help ensure the quality and integrity of essential management information, the directors continue to invest in a comprehensive data reporting system, segregation of duties, regular oversight, and a robust budgeting process. In addition, the Company operates a forecast process to develop the business's financial plans. It engages with its lenders when required to ensure sufficient liquidity for future anticipated economic scenarios.

The appointment of key staff is essential for shaping strategic decisions and ensuring longer-term succession planning and cultural influence.

The above activities help safeguard the business's success, ensuring that it acts fairly in the interests of the Company's shareholders, including maximising the financial returns to members.

Approved by the Board on 29 September 2025 and signed on its behalf by:


P E Moody
Chair

 

Campden BRI

Directors' Report for the Year Ended 31 December 2024

The directors present their report and the for the year ended 31 December 2024.

Directors of the company
The directors who held office during the year were as follows:

P E Moody - Chair (appointed Chair on 1 July 2025)

P Headridge

C Ikpeme

A L Kyriakides (appointed Vice Chair on 31 March 2025)

S Munden (resigned as Director and Chair on 1 June 2025)

S Newbitt

C M T Pronto-Hussey

Engagement with employees

Our people are committed to sharing their technical expertise with clients. We build technical capability through advice and training from experienced scientists to develop technical and laboratory skills. Culture is important at Campden BRI and key to how we deliver results and create a great place to work. We assess our culture through an annual employee engagement survey, where we listen to feedback about how we can make changes on both a team and organisational level. We aim to constantly improve levels of engagement within our business.

An independent Non-Executive Director was appointed in 2024, as the designated Non-Executive Director for employee engagement. This director’s role involves understanding the views and concerns of the workforce and articulating them in board meetings. By ensuring the appropriate steps are taken to evaluate the impact of proposals and developments on the workforce, and considering what steps should be taken to mitigate any adverse impact, this appointment is expected to enhance employee satisfaction and contribute to the company’s long-term success.

We encourage people to be themselves at work and bring their full range of skills. We recruit and promote people based on their talent, experience and technical skills, with an active aim for a diverse workforce. We do not tolerate any form of discrimination.

Social and community issues

The Campden BRI Group and its staff work with local schools and colleges to promote science concerning the food and drink industry as an academic and career choice. This includes staff involvement in supporting careers events, school visits, funding prizes in science, student work experience and placements.

The Streamlined Energy and Carbon Report (SECR) below describes our energy consumption and emissions and the improvements we have made this year.

The Group continues to seek ways to manage waste effectively through re-use, recycling and effective disposal to achieve an ongoing objective of zero operational waste to landfill.

Charitable donations

The Group made donations during the year of £1,537 (2023 - £1,400) for charitable purposes.

 

Campden BRI

Directors' Report for the Year Ended 31 December 2024

Environmental report

As part of our commitment to sustainability, we are pleased to report that our energy consumption continues to decrease year on year. This ongoing reduction reflects our dedication to integrating sustainable practices at the core of our operations and strategic plans.

Stated below is the Group's energy consumption, in kilowatt hours (kWh), and associated greenhouse gas ("GHG") emissions, in tonnes of carbon dioxide equivalent (tCO2e), and additional related information for the year, as required under the Companies (Directors' Report) and Limited Liability Partnerships (Energy and Carbon Report) Regulations 2018.

The methodology applied to the calculation of GHG emissions is the GHG Protocol Corporate Accounting and Reporting Standard which is available on the Greenhouse Gas Protocol website at
www.ghgprotocol.org/corporate-standard

Conversion factors have been taken from the U.K. Government's Greenhouse gas reporting: conversion factors 2024 which are available from the Government's website at
https://www.gov.uk/government/publications/greenhouse-gas-reporting-conversion-factors-2024

2024

2023

kWh

kWh

Total Energy Consumption (Scope 1 and Scope 2 - see below)

4,374,336

4,196,034

tCO2e

tCO2e

Emissions resulting from activities for which the Group is responsible involving the combustion of gas or the consumption of fuel for the purpose of transport (Scope 1)

437

383

Emissions resulting from the purchase of electricity by the Group for its own use, including for the purpose of transport (Scope 2)

417

441

Total emissions (Scope 1 and Scope 2)

854

824

Intensity Ratio (Scope 1 and Scope 2 emissions of tCO2e per £million of UK turnover)

32.23

32.48

Energy efficiency improvements made during the year:
• For company-owned sites, electricity contracts have been converted to renewable source energy.
• The continued replacement of existing lighting and heating products with LED lighting and energy efficient heating and air conditioning, where economically viable.
• Increased use of video conferencing technology for meetings to reduce travel requirements.

Engagement with suppliers, customers and other relationships

Suppliers of goods and services to the Group receive an official purchase order, which clearly states the terms of payment, which are net monthly.

Directors' insurance

The Company maintains insurance policies on behalf of all the Directors against liability arising from negligence, breach of duty and breach of trust in relation to the Company.

Disclosure of information to the auditor

Each director has taken the steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditor is unaware.

 

Campden BRI

Directors' Report for the Year Ended 31 December 2024

Reappointment of auditors

The auditor, Hazlewoods LLP, will be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

Approved by the Board on 29 September 2025 and signed on its behalf by:


P E Moody
Chair

 

Campden BRI

Statement of Directors' Responsibilities

The directors are responsible for preparing the Strategic Report, Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company and of the surplus of deficit of the group for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group's and the company's transactions and disclose with reasonable accuracy at any time the financial position of the group and the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Campden BRI

Independent Auditor's Report to the Members of Campden BRI

Opinion

We have audited the financial statements of Campden BRI (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024, which comprise the Consolidated Profit and Loss Account, Consolidated Statement of Comprehensive Income, Consolidated Balance Sheet, Balance Sheet, Consolidated Statement of Changes in Equity, Statement of Changes in Equity, Consolidated Statement of Cash Flows, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2024 and of the group's loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

 

Campden BRI

Independent Auditor's Report to the Members of Campden BRI

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

the parent company financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 12, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group’s and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Extent to which the audit was capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the nature of the group’s industry and its control environment and reviewed the group’s documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities.

We obtained an understanding of the legal and regulatory framework that the group operates in and identified the key laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements, including the UK Companies Act and tax legislation, and, those that do not have a direct effect on the financial statements but compliance with which may be fundamental to the group’s ability to operate or to avoid a material penalty.

We discussed among the audit engagement team regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

 

Campden BRI

Independent Auditor's Report to the Members of Campden BRI

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override of controls. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgments made in accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.

In addition to the above, our procedures to respond to the risks identified included the following:

reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;

performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatements due to fraud;

enquiring of management concerning actual and potential litigation and claims and instances of non-compliance with laws and regulations; and

reading minutes of meetings of those charged with governance.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company’s guarantor members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s guarantor members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s guarantor members as a body, for our audit work, for this report, or for the opinions we have formed.





Scott Lawrence (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor

Staverton Court
Staverton
Cheltenham
GL51 0UX

29 September 2025

 

Campden BRI

Consolidated Profit and Loss Account for the Year Ended 31 December 2024

Note

2024
£

2023
£

Turnover

3

26,670,924

26,048,990

Cost of sales

 

(15,795,733)

(14,391,001)

Gross profit

 

10,875,191

11,657,989

Administrative expenses

 

(10,260,681)

(9,755,568)

Other operating income

4

244,102

-

Operating profit

5

858,612

1,902,421

Exceptional expenses

6

(990,920)

-

Interest receivable and similar income

31,123

-

Interest payable and similar expenses

7

(291,835)

(106,000)

(Loss)/profit before tax

 

(393,020)

1,796,421

Tax on (loss)/profit

11

269,798

(288,203)

(Loss)/profit for the financial year

 

(123,222)

1,508,218

2024
£

2023
£

(Loss)/profit for the year

(123,222)

1,508,218

Deficit on property, plant and equipment revaluation

(4,175,000)

-

Remeasurement gain/(loss) on defined benefit pension schemes

5,909,000

(5,253,196)

Deferred tax on defined benefit pension obligations

(1,428,541)

1,400,500

305,459

(3,852,696)

Total comprehensive income for the year

182,237

(2,344,478)

The above results were derived from continuing operations.

 

Campden BRI

(Registration number: 00510618)
Consolidated Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

12

99,338

-

Tangible assets

13

13,654,366

17,686,934

 

13,753,704

17,686,934

Current assets

 

Inventories

15

110,327

85,135

Debtors

16

7,391,122

7,157,609

Cash at bank and in hand

 

752,986

3,073,688

 

8,254,435

10,316,432

Creditors: Amounts falling due within one year

18

(7,047,695)

(7,308,110)

Net current assets

 

1,206,740

3,008,322

Total assets less current liabilities

 

14,960,444

20,695,256

Creditors: Amounts falling due after more than one year

18

(116,667)

(316,667)

Provisions for liabilities

20

(744,879)

(1,119,428)

Net assets excluding pension asset/(liability)

 

14,098,898

19,259,161

Pension liability

21

(333,000)

(7,387,000)

Deferred tax asset on pension scheme liability

 

83,500

1,795,000

21

(249,500)

(5,592,000)

Net assets

 

13,849,398

13,667,161

Reserves

 

Revaluation reserve

1,784,209

5,959,209

Retained earnings

12,065,189

7,707,952

Total equity

 

13,849,398

13,667,161

Approved and authorised by the Board on 29 September 2025 and signed on its behalf by:
 

P E Moody
Chair

 

Campden BRI

(Registration number: 00510618)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Investments

14

6,035,879

6,035,879

Current assets

 

Debtors

16

9,522,320

9,248,209

Cash at bank and in hand

 

3,315

3,410

 

9,525,635

9,251,619

Creditors: Amounts falling due within one year

18

(1,160,408)

(1,199,375)

Net current assets

 

8,365,227

8,052,244

Net assets excluding pension asset/(liability)

 

14,401,106

14,088,123

Pension liability

21

(333,000)

(7,180,000)

Deferred tax asset on pension scheme liability

 

83,500

1,795,000

21

(249,500)

(5,385,000)

Net assets

 

14,151,606

8,703,123

Reserves

 

Retained earnings

14,151,606

8,703,123

Total equity

 

14,151,606

8,703,123

The company made a profit after tax for the financial year of £1,162,024 (2023 - profit of £1,318,945).

Approved and authorised by the Board on 29 September 2025 and signed on its behalf by:
 

P E Moody
Chair

 

Campden BRI

Consolidated Statement of Changes in Equity for the Year Ended 31 December 2024
Equity attributable to the parent company

Revaluation reserve
£

Retained earnings
£

Total
£

At 1 January 2023

5,959,209

10,052,430

16,011,639

Surplus for the year

-

1,508,218

1,508,218

Remeasurement gain/(loss) on defined benefit pension schemes

-

(5,253,196)

(5,253,196)

Deferred tax on defined benefit pension obligations

-

1,400,500

1,400,500

Total comprehensive income

-

(2,344,478)

(2,344,478)

At 31 December 2023

5,959,209

7,707,952

13,667,161

Revaluation reserve
£

Retained earnings
£

Total
£

At 1 January 2024

5,959,209

7,707,952

13,667,161

Deficit for the year

-

(123,222)

(123,222)

Deficit on property, plant and equipment revaluation

(4,175,000)

-

(4,175,000)

Remeasurement gain/(loss) on defined benefit pension schemes

-

5,909,000

5,909,000

Deferred tax on defined benefit pension obligations

-

(1,428,541)

(1,428,541)

Total comprehensive income

(4,175,000)

4,357,237

182,237

At 31 December 2024

1,784,209

12,065,189

13,849,398

 

Campden BRI

Statement of Changes in Equity for the Year Ended 31 December 2024

Retained earnings
£

At 1 January 2023

11,585,678

Profit for the year

1,318,945

Remeasurement gain/(loss) on defined benefit pension schemes

(5,602,000)

Deferred tax on defined benefit pension obligations

1,400,500

Total comprehensive income

(2,882,555)

At 31 December 2023

8,703,123

Retained earnings
£

At 1 January 2024

8,703,123

Profit for the year

1,162,024

Remeasurement gain/(loss) on defined benefit pension schemes

5,715,000

Deferred tax on defined benefit pension obligations

(1,428,541)

Total comprehensive income

5,448,483

At 31 December 2024

14,151,606

 

Campden BRI

Consolidated Statement of Cash Flows for the Year Ended 31 December 2024

Note

2024
 £

2023
 £

Cash flows from operating activities

(Loss)/profit for the year

 

(123,222)

1,508,218

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

5

990,483

772,715

Profit on disposal of tangible assets

(31,650)

-

Finance income

(31,123)

-

Finance costs

7

291,835

106,000

Income tax expense

11

(269,798)

288,203

Difference between provision for pension liabilities charged against operating surplus and contributions paid in the year

 

(1,411,000)

(1,219,000)

Foreign exchange gains/losses

 

23,493

(240)

 

(560,982)

1,455,896

Working capital adjustments

 

(Increase)/decrease in inventories

15

(25,192)

39,530

Increase in accounts receivable

16

(123,422)

(362,634)

(Decrease)/increase in accounts payable

18

(285,191)

500,028

Cash generated from operations

 

(994,787)

1,632,820

Income taxes received/(paid)

11

27,668

(2,305)

Net cash flow from operating activities

 

(967,119)

1,630,515

Cash flows from investing activities

 

Interest received

31,123

-

Acquisitions of tangible assets

(1,123,710)

(1,368,658)

Proceeds from sale of tangible assets

 

38,342

-

Acquisition of intangible assets

12

(99,338)

-

Net cash flows from investing activities

 

(1,153,583)

(1,368,658)

Cash flows from financing activities

 

Repayment of bank borrowing

 

(200,000)

(200,000)

Net (decrease)/increase in cash and cash equivalents

 

(2,320,702)

61,857

Cash and cash equivalents at 1 January

 

3,073,688

3,011,831

Cash and cash equivalents at 31 December

 

752,986

3,073,688

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

1

General information

The company is a company limited by guarantee, incorporated in England and Wales, and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £5 towards the assets of the company in the event of liquidation.

The address of its registered office is:
Station Road
Chipping Campden
Gloucestershire
GL55 6LD

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Basis of consolidation

The consolidated financial statements consolidate the financial statements of the company and its subsidiary undertakings drawn up to 31 December 2024.

No Profit and Loss Account is presented for the company as permitted by section 408 of the Companies Act 2006. The company made a profit after tax for the financial year of £1,162,024 (2023 - £1,318,945).

A subsidiary is an entity controlled by the company. Control is achieved where the company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

The results of subsidiaries acquired or disposed of during the year are included in the Profit and Loss Account from the effective date of acquisition or up to the effective date of disposal, as appropriate. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by the group.

The purchase method of accounting is used to account for business combinations that result in the acquisition of subsidiaries by the group. The cost of a business combination is measured as the fair value of the assets given, equity instruments issued and liabilities incurred or assumed at the date of exchange, plus costs directly attributable to the business combination. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Any excess of the cost of the business combination over the acquirer’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities recognised is recorded as goodwill.

Inter-company transactions, balances and unrealised gains on transactions between the company and its subsidiaries, which are related parties, are eliminated in full.

Intra-group losses are also eliminated but may indicate an impairment that requires recognition in the consolidated financial statements.

Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the group. Non-controlling interests in the net assets of consolidated subsidiaries are identified separately from the group’s equity therein. Non-controlling interests consist of the amount of those interests at the date of the original business combination and the non-controlling shareholder’s share of changes in equity since the date of the combination.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

Application of merger accounting
The Group has applied a true and fair override in respect of the merger between Campden BRI and Campden BRI (Nutfield). Details of this judgement can be found in the accounting policies set out below.

Key sources of estimation uncertainty

Defined benefit pension schemes
The measurement of obligations under defined benefit pension scheme arrangements is subject to a number of highly sensitive assumptions, details of which are given in note 15 of the financial statements. The carrying value of amounts recognised in the Group financial statements in respect of defined benefit pension obligations, net of related deferred tax, are £250,500 (2023 - £5,592,000). Where the fair value of pension scheme assets exceed the present value of pension scheme obligations, the surplus is only recognised to the extent that the Group is able to realise the surplus either during the life of the scheme or when the scheme is settled. At 31 December 2024, a surplus of £1,541,000 was recognised (2023 - £1,207,000) in relation to the FMBRA pension scheme.

Deferred tax
The Group is subject to UK corporation tax and judgement is required in determining the provision for income and deferred taxation. The Group recognises taxation assets and liabilities based upon estimates and assessments of many factors including judgements about the outcome of future events. Deferred tax assets are only recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. At 31 December 2024 the Company has recognised a deferred tax asset in respect of defined benefit pension scheme obligations of £83,500 (2023 - £1,795,000) on the basis that the Group is, and remains, in a tax paying position.

Revenue recognition
The recognition of revenue on long term contracts is subject to estimates in respect of the stage of project completion and the overall profitability of each contract. Details of the methodology applied can be found in the accounting policies set out below.

Valuation of freehold property
The freehold land and buildings were revalued on 31 December 2024 by an independent valuer, on a fair value basis. Also included within the value of freehold land and buildings at 31 December 2024 are assets of £30,576 purchased in 2023 and additions in the current year of £36,937.

Going concern

The Board assesses whether the use of going concern is appropriate, i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the Group to continue as a going concern. The Board makes this assessment in respect of a period of one year from the date of approval of the financial statements.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

True and fair override

The merger of Campden BRI and Campden BRI (Nutfield) does not meet the conditions for merger accounting as defined by the Companies Act because neither entity has share capital. The Companies Act does not consider business combinations of not for profit organisations where the parties to the combination are limited by guarantee with no share capital. Because the conditions for accounting for a business combination as a merger are not met, the Companies Act requires Campden BRI to account for the business combination as an acquisition. However, if the criteria defined by the Companies Act were to be applied to the merger with Campden BRI (Nutfield), merger accounting would be applied. Upon this basis, merger accounting has historically been applied.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the group’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the group.

The group recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the group's activities.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Foreign currency transactions and balances

The individual financial statements of each Group entity are presented in the currency of the primary economic environment in which the entity operates (its functional currency). For the purpose of the consolidated financial statements, the results and financial position are presented in Sterling.

Monetary assets and liabilities denominated in foreign currencies are translated into Sterling at the rates of exchange ruling at the balance sheet date or if appropriate at the forward contract date. Non-monetary assets denominated in foreign currencies are translated into Sterling at the rate of exchange ruling at the date of acquisition of the asset. Transactions denominated in foreign currencies are translated into Sterling at the rate of exchange ruling at the date of the transaction. All revaluation differences and realised exchange differences are taken to the income statement.

For the purpose of presenting consolidated financial statements, the assets and liabilities of the Group's foreign operations are translated from their functional currency to Sterling using the closing exchange rate. Income and expenses are translated using the average rate for the period, unless exchange rates fluctuated significantly during that period, in which case the exchange rates at the dates of the transactions are used. Exchange differences arising on the translation of Group companies are recognised in other comprehensive income and are not reclassified to profit or loss.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the group operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the consolidated financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold property

None

Plant and equipment

3 to 10 years

Motor vehicles

4 years

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the group’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Negative goodwill arising on an acquisition is recognised on the face of the balance sheet on the acquisition date and subsequently the excess up to the fair value of non-monetary assets acquired is recognised in profit or loss in the periods in which the non-monetary assets are recovered.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Internally generated software under construction

Amortised when assets are brought into use

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the group will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the group does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the group has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Provisions

Provisions are recognised when the group has an obligation at the reporting date as a result of a past event, it is probable that the group will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the group has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Defined benefit pension obligation

Typically defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.

The liability recognised in the balance sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the reporting date minus the fair value of plan assets. The defined benefit obligation is measured using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future payments by reference to market yields at the reporting date on high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating to the terms of the related pension liability.

Actuarial gains and losses are charged or credited to other comprehensive income in the period in which they arise.

Campden RA Pension Scheme ("Campden"), Flour Milling and Baking Research Association Pension and Assurance Scheme ("FMBRA") and British Beer and Pub Association Group Pension Fund ("BBPA")

The assets of the schemes are held separately from those of the Group, being invested through investment management companies. Contributions to the schemes are paid by Campden BRI (Chipping Campden) Limited in respect of the Campden and FMBRA Schemes and by Campden BRI (Nutfield) in respect of the BBPA Scheme. Full actuarial valuations, by a professionally qualified actuary are obtained at least every three years, and are updated to reflect current conditions at each balance sheet date. The date of the last full actuarial valuation for Campden was 1 January 2020; FMBRA was 1 January 2020 and 30 September 2020 in respect of the BBPA.

Scheme assets are measured at fair values. Scheme liabilities are measured on an actuarial basis and are discounted at the appropriate high quality corporate bond rates.

The net surplus or deficit, adjusted for deferred tax where appropriate, is presented separately from other net assets on the Statement of financial position as part of the Group's pension scheme liability. A net surplus is recognised only to the extent that it is recoverable by the Group.

The current service cost and costs from settlements and curtailments are charged to the income statement. Interest on the scheme liabilities and on scheme assets are included in other finance costs. Actuarial gains and losses, and the expected return on scheme assets, are reported in other comprehensive income.

Universities Superannuation Scheme ("USS")

The assets of the scheme are held separately from those of the Group, being invested by the scheme's investment managers. Contributions to the scheme are paid by Campden BRI (Nutfield).

It is not possible to identify the Group's share of the underlying assets and liabilities in the scheme. Therefore, under FRS 102, with the exception of the obligations arising under deficit funding agreements, the scheme is accounted for as if it were a defined contribution scheme with employer contributions payable in the period expensed in the consolidated statement of comprehensive income statement. Differences between contributions payable in the period and contributions paid are shown either as accruals or prepayments in the consolidated statement of financial position.

The Group and other participating employers have entered into a deficit funding agreement with the Universities Superannuation Scheme. The present values of the Group's commitments under this agreement have been recognised as a liability in the Statement of financial position. The discount rate used reflects that used in the valuation of the British Beer & Pub Association Scheme as set out below. The obligation recognised represents an employer contribution of 2.0% to September 2021, 0% between October 2021 and March 2022 and 6.3% from April 2022 to March 2028. The deficit contribution is part of the total employer contributions of 21.1% to September 2021, and 21.4% from October 2021, in accordance with the scheme schedule of contributions.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Financial Instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.
 

Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Financial assets and liabilities are only offset in the balance sheet when, and only when, there exists a legally enforceable right to set off the recognised amounts and the company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
 

Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

Non-financial assets:
An asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Financial assets:
For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

3

Turnover

The analysis of the group's Turnover for the year from continuing operations is as follows:

2024
£

2023
£

Rendering of services

26,670,924

26,048,990

The analysis of the group's Turnover for the year by market is as follows:

2024
£

2023
£

UK

18,664,959

18,309,088

Europe

4,932,051

4,473,033

Rest of world

3,073,914

3,266,869

26,670,924

26,048,990

 

4

Other operating income

The analysis of the group's other operating income for the year is as follows:

2024
£

2023
£

Research and development tax credits

244,102

-

 

5

Operating profit

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

990,483

772,715

Foreign exchange losses

17,312

-

 

6

Exceptional items

2024
 £

2023
 £

Exceptional expenses

990,920

-

The exceptional expenses relate to the closure of the Nutfield site that occurred in the year, as well as legal and professional fees.

 

7

Interest payable and similar expenses

2024
£

2023
£

Interest expense on other finance liabilities

4,835

-

Other finance costs

287,000

106,000

291,835

106,000

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

8

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2024
£

2023
£

Wages and salaries

13,151,457

11,755,042

Social security costs

1,362,886

1,165,890

Other pension costs

495,400

566,961

Net interest cost under FRS 102

8,000

3,000

Redundancy costs

240,769

76,634

15,258,512

13,567,527

The average number of persons employed by the group (including directors) during the year, analysed by category was as follows:

2024
 No.

2023
 No.

Administration and support

84

71

Technical

274

276

358

347

 

9

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

755,720

404,105

Contributions paid to money purchase schemes

16,119

13,499

771,839

417,604

During the year the number of directors who were receiving benefits and share incentives was as follows:

2024
No.

2023
No.

Accruing benefits under money purchase pension scheme

1

1

In respect of the highest paid director:

2024
£

2023
£

Remuneration

256,339

224,226

 

10

Auditors' remuneration

2024
£

2023
£

Audit of these financial statements

47,019

43,708

Other fees to auditors

All other non-audit services

34,390

2,073

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024


 

 

11

Taxation

Tax charged/(credited) in the consolidated profit and loss account

2024
£

2023
£

Current taxation

UK corporation tax adjustment to prior periods

(179,406)

-

Foreign tax

1,198

2,305

Total current income tax

(178,208)

2,305

Deferred taxation

Arising from origination and reversal of timing differences

(404,762)

3,558

Arising from changes in tax rates and laws

-

3,340

Arising from previously unrecognised tax loss, tax credit or temporary difference of prior periods

30,213

-

Arising from amounts charged to the income statement in respect of defined benefit pension scheme obligations

282,959

279,000

Total deferred taxation

(91,590)

285,898

Tax (receipt)/expense in the income statement

(269,798)

288,203

The tax on profit before tax for the year is lower than the standard rate of corporation tax in the UK (2023 - lower than the standard rate of corporation tax in the UK) of 25% (2023 - 23.52%).

The differences are reconciled below:

2024
£

2023
£

(Deficit)/surplus before tax

(393,020)

1,796,421

Corporation tax at standard rate

(98,255)

422,518

Tax increase/(decrease) from effect of capital allowances and depreciation

860

(51,111)

Effect of expense not deductible in determining taxable profit (tax loss)

1,150

22,558

Increase from tax losses for which no deferred tax asset was recognised

215,506

8,628

Decrease in UK and foreign current tax from unrecognised temporary difference from a prior period

(179,406)

-

Deferred tax expense from unrecognised temporary difference from a prior period

30,213

-

Deferred tax expense relating to changes in tax rates or laws

-

3,340

Tax decrease from effect of adjustment in research and development tax credit

(30,213)

-

Tax decrease from effect of indexation allowance on capital gains

(121,552)

(16,765)

Tax decrease from other tax effects

(88,101)

(100,965)

Total tax (credit)/charge

(269,798)

288,203

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Deferred tax

Group

Deferred tax assets and liabilities

2024

Asset
£

Liability
£

Accelerated capital allowances

-

1,477,040

Revaluation of property

-

84,166

Tax losses

770,300

-

Other timing differences

46,027

-

816,327

1,561,206

2023

Asset
£

Liability
£

Accelerated capital allowances

-

1,422,526

Revaluation of property

-

205,718

Tax losses

453,467

-

Other timing differences

55,349

-

508,816

1,628,244

There is a deferred tax asset not recognised of £2,057,518 (2023 - £1,825,853) on the basis that the timing of its recoverability cannot be assessed with any certainty. The deferred tax asset largely relates to tax losses of £7,809,916 (2023 - £7,010,049) which are available to carry forward against future tax profits.

 

12

Intangible assets

Group

Internally generated software under construction
 £

Cost

At 1 January 2024

-

Additions

99,338

At 31 December 2024

99,338

Carrying amount

At 31 December 2024

99,338

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

13

Tangible assets

Group

Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Assets under construction
£

Total
£

Cost

At 1 January 2024

13,830,576

13,934,087

83,516

508,135

28,356,314

Revaluations

(4,175,000)

-

-

-

(4,175,000)

Additions

36,937

1,208,590

17,717

24,690

1,287,934

Disposals

-

(1,438,509)

-

-

(1,438,509)

Transfers

-

508,135

-

(508,135)

-

Foreign exchange movements

-

(8,860)

(8,158)

-

(17,018)

At 31 December 2024

9,692,513

14,203,443

93,075

24,690

24,013,721

Depreciation

At 1 January 2024

-

10,631,579

37,801

-

10,669,380

Charge for the year

-

978,894

11,589

-

990,483

Eliminated on disposal

-

(1,289,671)

-

-

(1,289,671)

Foreign exchange movements

-

(7,777)

(3,060)

-

(10,837)

At 31 December 2024

-

10,313,025

46,330

-

10,359,355

Carrying amount

At 31 December 2024

9,692,513

3,890,418

46,745

24,690

13,654,366

At 31 December 2023

13,830,576

3,302,508

45,715

508,135

17,686,934

Included within the net book value of land and buildings above is £9,692,513 (2023 - £13,830,576) in respect of freehold land and buildings.

The freehold land and buildings at the Chipping Campden site was revalued as at 31 December 2024 by independent valuer, Alder King property consultants, on a fair value basis. They have confirmed that the value as at that date was £2,175,000 for the land and £5,200,000 for the buildings.

The freehold land and buildings at the Nutfield site was revalued as at 31 December 2024 by independent valuer, Vail Williams, on a fair value basis. They have confirmed that the value as at that date was £2,250,000.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

14

Investments

Company

2024
£

2023
£

Investments in subsidiaries

6,035,879

6,035,879

Subsidiaries

£

Cost

At 1 January 2024 and 31 December 2024

6,035,879

Carrying amount

At 31 December 2024

6,035,879

At 31 December 2023

6,035,879

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2024

2023

Subsidiary undertakings

Campden BRI (Chipping Campden) Limited

Station Road, Chipping Campden, Gloucestershire, GL55 6LD

Ordinary

100%

100%

Campden BRI Magyarorszag

Hungary

Ordinary

100%

100%

Subsidiary undertakings

Campden BRI (Chipping Campden) Limited

The principal activity of Campden BRI (Chipping Campden) Limited is Food and drink consultancy and training services.

Campden BRI Magyarorszag

The principal activity of Campden BRI Magyarorszag is Food and drink consultancy and training services.

In addition, the Group has a controlling interest in Campden BRI (Nutfield), a company limited by guarantee, as the sole member of the company. Campden BRI (Nutfield) was incorporated in England and Wales and its business is that of food and drink consultancy and training services.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

15

Inventories

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Consumables

110,327

85,135

-

-

 

16

Debtors

   

Group

Company

Note

2024
£

2023
£

2024
£

2023
£

Trade debtors

 

4,762,212

4,604,068

-

-

Amounts owed by related parties

25

-

-

9,503,836

9,174,128

Other debtors

 

127,702

16,653

-

-

Prepayments

 

801,315

940,315

18,484

74,081

Gross amount due from customers for contract work

 

1,334,043

1,381,263

-

-

Corporation tax asset

11

365,850

215,310

-

-

 

7,391,122

7,157,609

9,522,320

9,248,209

 

17

Cash and cash equivalents

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Cash

3,955

4,207

-

-

Cash at bank

749,031

3,069,481

3,315

3,410

752,986

3,073,688

3,315

3,410

 

18

Creditors

   

Group

Company

Note

2024
£

2023
£

2024
£

2023
£

Due within one year

 

Loans

19

224,776

200,000

-

-

Trade creditors

 

1,113,460

1,569,828

-

-

Amounts due to related parties

25

-

-

1,160,408

1,219,992

Social security and other taxes

 

867,464

753,851

-

-

Outstanding defined contribution pension costs

 

149,276

132,351

-

-

Other payables

 

2,487,493

2,385,173

-

-

Accruals

 

585,670

608,322

-

(20,617)

Gross amount due to customers for contract work

 

1,619,556

1,658,585

-

-

 

7,047,695

7,308,110

1,160,408

1,199,375

Due after one year

 

Loans

19

116,667

316,667

-

-

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

19

Loans

Current loans and borrowings

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Bank borrowings

200,000

200,000

-

-

Other borrowings

24,776

-

-

-

224,776

200,000

-

-

Non-current loans and borrowings

 

Group

Company

2024
£

2023
£

2024
£

2023
£

Bank borrowings

116,667

316,667

-

-

The bank loan is provided under the UK Government's Coronavirus Business Interruption Loan Scheme, and is secured by a fixed charge over the land and buildings at Station Road, Chipping Campden and inter company cross guarantee. The loan is repayable over the period until July 2026. The interest rate is Base Rate +2.6%.

 

20

Provisions for liabilities

Group

Deferred tax
£

Deferred tax asset on pension scheme liability
£

Total
£

At 1 January 2024

1,119,428

(1,795,000)

(675,572)

Increase (decrease) in existing provisions

(374,549)

1,711,500

1,336,951

At 31 December 2024

744,879

(83,500)

661,379

Company

Deferred tax asset on pension scheme liability
£

Total
£

At 1 January 2024

(1,795,000)

(1,795,000)

Increase (decrease) in existing provisions

1,711,500

1,711,500

At 31 December 2024

(83,500)

(83,500)

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

21

Pension and other schemes

Defined contribution pension scheme

The group operates a defined contribution pension scheme for certain employees. The scheme is compliant for Auto-Enrolment purposes. The assets of the scheme are held separately from those of the Group in independently administered funds. Contributions are charged to the Statement of comprehensive income as they become payable in accordance with the rules of the scheme. The pension cost charge for the year represents contributions payable by the group to the scheme and amounted to £495,400 (2023 - £566,961).

Contributions totalling £149,276 (2023 - £132,351) were payable to the scheme at the end of the year and are included in creditors.

Defined benefit pension schemes

Campden RA Pension Scheme

The contributions to this scheme are determined with advice from an independent qualified actuary on the basis of triennial valuation.

The date of the most recent comprehensive actuarial valuation was 31 March 2023. The valuation showed that the market value of the scheme's assets at that date was £36,768,000 and that the actuarial value was sufficient to cover 86% of the value of the benefits that had accrued to members, after allowing for earnings increases and guaranteed pension increases.

Following the valuation, the Group is required to contribute in accordance with a schedule provided by the actuary to satisfy the long term funding of the scheme. The schedule continues until 1 March 2029. Contributions of £1,305,000 (2023 - £1,118,000) were made in the year.

The scheme was closed (for future accrual of benefits) to existing members on 1 January 2011.

Flour Milling and Baking Research Association Pension and Assurance Scheme

The contributions to this scheme are determined with advice from an independent qualified actuary on the basis of triennial valuation.

The date of the most recent comprehensive actuarial valuation was 01 January 2023. The valuation showed that the market value of the scheme's assets at that date was £11,076,000 and that the actuarial value was sufficient to cover 111% of the value of the benefits that had accrued to members, after allowing for earnings increases and guaranteed pension increases.

Following the valuation, the actuarial advice is that the Group should cease to contribute in accordance with the schedule of contributions as the long-term funding objective of the scheme has been achieved. Contributions of £114,000 (2023 - £104,000) were made in the year.

The scheme was closed (for future accrual of benefits) to existing members on 31 March 2012.

British Beer & Pub Association Group Pension Fund

Campden BRI (Nutfield) is a participating employer in the British Beer & Pub Association Group Pension Fund ("the scheme"). The assets of the Scheme are held in a separate trustee administered fund. The Scheme closed to future accrual on 1 December 2011. A schedule of contributions is agreed between the Company and the trustees after each comprehensive actuarial valuation.

The date of the most recent comprehensive actuarial valuation was 15 March 2025. This showed that Campden BRI (Nutfield)'s share of the Schemes liabilities was 21%. These disclosures have been prepared on the basis that Campden BRI (Nutfield)'s share of Scheme's assets is 21%.

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Universities Superannuation Scheme

As a participating employer in the Universities Superannuation Scheme (USS), the Group previously recognised a liability in the Statement of Financial Position for its share of the scheme's deficit, based on the former schedule of contributions, which included a deficit recovery component.

The date of the most recent comprehensive actuarial valuation was 01 January 0001. The valuation was carried out using the projected unit method. At the valuation date, the scheme's assets were valued at £73.1 billion, while the past service liabilities were valued at £65.7 billion, resulting in a surplus of £7.4 billion, representing 111% coverage of benefits.

The scheme’s assets are held separately from those of the Group and are managed by the scheme's investment managers. Contributions to the scheme are paid by Campden BRI (Nutfield) and other participating employers. It is not possible to identify the Group's share of the underlying assets and liabilities in the scheme. Therefore, under FRS 102, with the exception of obligations arising under deficit funding agreements, the scheme is accounted for as if it were a defined contribution scheme, with employer contributions expensed in the period in the Statement of Comprehensive Income. Differences between contributions payable and contributions paid are recorded as either accruals or prepayments in the Statement of Financial Position.

Up until 31 December 2023, the Group contributed at a rate of 21.6%, which included a 6% deficit contribution. Following the 31 March 2023 valuation, it was determined that the scheme’s assets are now sufficient to meet the technical provisions, achieving the scheme's long-term funding objective.

As a result, effective from 1 January 2024, the employer contribution rate was reduced to 14.5%, with no portion of these contributions allocated towards deficit recovery. Consequently, the Group and other participating employers are no longer required to contribute towards the deficit under the revised schedule.

The previously recognised liability related to the deficit funding agreement has been derecognised, and no further liability is reflected in the Statement of Financial Position for the year ended 31 December 2023.

The scheme remains open to new entrants. The eligibility rules were amended from 1 December 2013 and restrict new entrants to those in "academic" equivalent roles defined as Heads of Department and Directors employed by Campden BRI (Nutfield).

Defined benefit scheme liability

The amounts recognised in the Statement of Financial Position are as follows:

2024

2023

£

£

Present value of funded obligations

1,741,000

(7,387,000)

Present value of deficit funding obligations to the Universities Superannuation Scheme

-

-

Surplus/(Deficit) in scheme

1,741,000

(7,387,000)

Surplus not recognised

(2,074,000)

-

Deficit included in Statement of financial position

(333,000)

(7,387,000)

Related deferred tax asset

83,500

1,795,000

Net Group liability

(249,500)

(5,592,000)

Surplus/(Deficit) included in Group Statement of Financial Position

(333,000)

(7,387,000)

Deficit in respect of Campden BRI (Nutfield)

-

207,000

Deficit included in Company Statement of Financial Position

(333,000)

(7,180,000)

Deferred tax asset in respect of Campden BRI

83,500

1,795,000

Net company liability

(249,500)

(5,385,000)

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Reconciliation of scheme assets and liabilities to assets and liabilities recognised

The amounts recognised in the balance sheet are as follows:

2024
£

2023
£

Fair value of scheme assets

51,166,000

49,751,000

Present value of defined benefit obligation

(49,425,000)

(57,138,000)

1,741,000

(7,387,000)

Opening (deficit)

(7,387,000)

(2,770,000)

Employer contributions

1,440,000

1,243,000

Credit/(charge) recorded in the P&L

(295,000)

(109,000)

Gain/(loss) recorded in OCI

7,983,000

(5,751,000)

Asset ceiling adjustment

(2,074,000)

-

(333,000)

(7,387,000)

Defined benefit obligation

Changes in the defined benefit obligation are as follows:

2024
£

Present value at start of year

57,138,000

Interest cost

2,398,000

Actuarial gains and losses

(7,337,000)

Benefits paid

(2,774,000)

Present value at end of year

49,425,000

Fair value of scheme assets

Changes in the fair value of scheme assets are as follows:

2024
£

Fair value at start of year

49,751,000

Interest income

2,102,000

Return on plan assets, excluding amounts included in interest income/(expense)

647,000

Employer contributions

1,440,000

Benefits paid

(2,774,000)

Fair value at end of year

51,166,000

Analysis of assets

The major categories of scheme assets are as follows:

2024
£

2023
£

Cash and cash equivalents

18,449,000

16,140,000

Equity instruments

1,067,000

1,302,000

Gilts

10,990,000

12,790,000

Property

8,250,000

9,140,000

Corporate and Government Bonds

12,410,000

10,379,000

51,166,000

49,751,000

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

Return on scheme assets

2024
£

2023
£

Return on scheme assets

2,749,000

1,446,000

The pension scheme has not invested in any of the group's own financial instruments or in properties or other assets used by the group.

Principal actuarial assumptions

The principal actuarial assumptions at the balance sheet date are as follows:

2024
%

2023
%

Discount rate

5.40

4.30

Retail price inflation

3.20

3.20

Consumer price inflation (Until 2030)

2.40

2.40

Consumer price inflation (After 2030)

3.20

3.20

Pension increases: RPI max 5.0% min 3.0%

3.70

3.70

Pension increases: RPI max 5.0%

3.10

3.10

Pension increases: RPI max 2.5%

2.10

2.10

Post retirement mortality assumptions

2024
Years

2023
Years

Current UK pensioners at retirement age - male

21.00

21.00

Current UK pensioners at retirement age - female

24.00

24.00

Future UK pensioners at retirement age - male

22.00

22.00

Future UK pensioners at retirement age - female

25.00

25.00

The assumptions used in determining the overall expected return of the schemes' assets have been set with reference to yields available on government bonds and appropriate risk margins, in accordance with the requirements of FRS 102.

 

22

Obligations under leases and hire purchase contracts

Group

Operating leases

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

321,528

357,732

Later than one year and not later than five years

511,313

547,213

Later than five years

-

3,259

832,841

908,204

The amount of non-cancellable operating lease payments recognised as an expense during the year was £410,255 (2023 - £312,538).

 

Campden BRI

Notes to the Financial Statements for the Year Ended 31 December 2024

 

23

Contingent liabilities

Company

The Company is bound by an unlimited multilateral cross company guarantee arrangement with Campden BRI (Chipping Campden) Limited and Campden BRI (Nutfield). The guarantee is secured by a fixed charge over the freehold land and property at Station Road, Chipping Campden and covers the Group's facility, although there are currently no borrowings under that facility.

 

24

Analysis of changes in net debt

Group

At 1 January 2024
£

Cash flows
£

New finance leases
£

At 31 December 2024
£

Cash and cash equivalents

Cash

3,073,688

(2,320,702)

-

752,986

Borrowings

Long term borrowings

(316,667)

200,000

-

(116,667)

Short term borrowings

(200,000)

-

(24,776)

(224,776)

(516,667)

200,000

(24,776)

(341,443)

 

2,557,021

(2,120,702)

(24,776)

411,543

 

25

Related party transactions

During the year the Group received fees and subscriptions from some companies of which members of the Board are directors. All transactions were at arms-length and in the ordinary course of business. The total value of these fees was £203,139 (2023 - £621,278). Included in trade debtors at 31 December 2024 was £75,910 (2023 - £179,978) owed by such related parties.

Company

Summary of transactions with key management

Key management personnel are considered to be the directors of the company and key management personnel compensation is disclosed in note 7 to the financial statements.
 

 

26

Members liability

The Company is a company limited by guarantee, the individual members of Campden BRI having a liability not exceeding £5.00 each.

The membership numbers for the company is as follows:

2024
No.

2023
No.

Campden BRI

7

7